Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

GLPGGLPG
Showing 7 of 28 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in LAKEFRONT BIOTHERAPEUTICS NV

Yes. Susquehanna International Group holds 151,886 shares of GLPG (Lakefront Biotherapeutics), worth $4.6M, as of its Q2 2026 13F filing. It increased the position from 13,387 shares in Q1 2026. Susquehanna International Group has held GLPG since Q4 2025, across 3 quarterly 13F filings.

Current Value

$4.6M

Current Shares

151,886

Total Value Change

+$4.6M

Total Shares Change

+151,886

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
151,886
+1034.6%
$4.6M0.0%$27.73
43
2026-Q1
Increased
13,387
+92.1%
$401,6100.0%$33.05
26
2025-Q4
New
6,968
-
$227,8540.0%$32.61
35
2025-Q3
Exited
0
-100.0%
$00.0%$34.43
0
2025-Q2
Decreased
15,183
-33.7%
$424,9720.0%$27.98
0
2025-Q1
New
22,912
-
$575,5490.0%$25.46
34
2024-Q3
Exited
0
-100.0%
$00.0%$29.28
0

Other major holders of GLPG: SANDS CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used